BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Nephrol. Jun 25, 2026; 15(2): 118253
Published online Jun 25, 2026. doi: 10.5527/wjn.v15.i2.118253
Table 2 Immunosuppression in patients receiving early and late steroids, n (%)
Variables
Early (n = 84)
Late (n = 44)
P value (df for χ2)
Induction agent0.54 (2)
Basiliximab53 (63.1)25 (56.8)
ATG21 (25.0)15 (34.1)
None10 (11.9)4 (9.1)
Plasmapheresis28 (33.3)21 (47.7)0.11 (1)
Overall ATG use27 (32.1)18 (40.9)0.32 (1)
Bortezomib11 (1.2)4 (9.1)0.05 (1)
Mtor inhibitor2 (2.4)0 (0.0)0.54 (1)
Cyclosporine2 (2.4)1 (2.3)1.00 (1)
Azathioprine2 (2.4)3 (6.8)0.34 (1)


Write to the Help Desk